- Filed
- Oct 15, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Cash And Equivalents | Q3 2024 · Aug 31, 2024 | $197.44K |
| Cash And Equivalents | Q3 2024 · Nov 30, 2023 | $406.07K |
| Current Liabilities | Q3 2024 · Aug 31, 2024 | $17.42M |
| Current Liabilities | Q3 2024 · Nov 30, 2023 | $20.86M |
| Total Liabilities | Q3 2024 · Aug 31, 2024 | $72.49M |
| Total Liabilities | Q3 2024 · Nov 30, 2023 | $72.25M |
| Current Assets | Q3 2024 · Aug 31, 2024 | $10.66M |
| Current Assets | Q3 2024 · Nov 30, 2023 | $9.45M |
| Total Assets | Q3 2024 · Aug 31, 2024 | $62.93M |
| Total Assets | Q3 2024 · Nov 30, 2023 | $61.22M |
| Shares Diluted | Q3 2024 · Aug 31, 2023 | 8.34M sh |
| Shares Diluted | Q3 2024 · Aug 31, 2023 | 8.37M sh |
| Stock Repurchased | Q3 2024 · Aug 31, 2023 | $799.04K |
| Capex | Q3 2024 · Aug 31, 2023 | $5.12M |
| Operating Cash Flow | Q3 2024 · Aug 31, 2023 | $5.58M |
| Stockholders Equity | Q3 2024 · Aug 31, 2023 | −$16.16K |
| Stockholders Equity | Q3 2024 · May 31, 2023 | −$858.38K |
| Stockholders Equity | Q3 2024 · Nov 30, 2022 | −$1.52M |
| Eps Diluted | Q3 2024 · Aug 31, 2023 | $0.08 |
| Eps Diluted | Q3 2024 · Aug 31, 2023 | $0.20 |
| Eps Basic | Q3 2024 · Aug 31, 2023 | $0.08 |
| Eps Basic | Q3 2024 · Aug 31, 2023 | $0.20 |
| Sga Expense | Q3 2024 · Aug 31, 2023 | $3.8M |
| Sga Expense | Q3 2024 · Aug 31, 2023 | $11.72M |
| Rd Expense | Q3 2024 · Aug 31, 2023 | $344.13K |
| Rd Expense | Q3 2024 · Aug 31, 2023 | $727.65K |
| Net Income | Q3 2024 · Aug 31, 2023 | $680.56K |
| Net Income | Q3 2024 · Aug 31, 2023 | $1.67M |
| Operating Income | Q3 2024 · Aug 31, 2023 | $1.16M |
| Operating Income | Q3 2024 · Aug 31, 2023 | $3.87M |
| Cost Of Revenue | Q3 2024 · Aug 31, 2023 | $2.16M |
| Cost Of Revenue | Q3 2024 · Aug 31, 2023 | $6.37M |